PNC Financial Services Group
AMLX icon

PNC Financial Services Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

PNC Financial Services Group’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.29K Buy
406
+123
+43% +$1.9K ﹤0.01% 4236
2026
Q1 		$3.93K Sell
283
-155
-35% -$2.18K ﹤0.01% 4369
2025
Q4 		$5.29K Sell
438
-47
-10% -$638 ﹤0.01% 4218
2025
Q3 		$6.59K Buy
485
+432
+815% +$4.07K ﹤0.01% 4104
2025
Q2 		$340 Hold
53
– – ﹤0.01% 4735
2025
Q1 		$188 Hold
53
– – ﹤0.01% 4785
2024
Q4 		$200 Sell
53
-43
-45% -$202 ﹤0.01% 4650
2024
Q3 		$311 Hold
96
– – ﹤0.01% 4622
2024
Q2 		$182 Sell
96
-118
-55% -$229 ﹤0.01% 4680
2024
Q1 		$608 Buy
214
+18
+9% +$235 ﹤0.01% 4468
2023
Q4 		$2.88K Buy
+196
New +$3K ﹤0.01% 4100
2023
Q2 		– Sell
-100
Closed -$2.93K – 4729
2023
Q1 		$2.93K Buy
+100
New +$3.47K ﹤0.01% 4208

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PNC Financial Services Group's AMLX Position: Q2 2026 in Review

PNC Financial Services Group increased its Amylyx Pharmaceuticals (AMLX) stake by 43% in Q2 2026, buying an estimated $1.9K and bringing the position to 406 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #4236.

PNC Financial Services Group first reported a position in AMLX in Q1 2023 and has held it in 12 quarters since. 52 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • PNC Financial Services Group held 406 shares of Amylyx Pharmaceuticals worth $7.29K as of Q2 2026.
  • PNC Financial Services Group bought 123 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $1.9K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4236 holding.
  • PNC Financial Services Group first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
  • 52 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.